Selon les derniers rapports financiers de Glenmark Pharmaceuticals
, l'entreprise a 0.91 Milliard d'euros en actifs nets.
Les actifs nets d'une entreprise sont la somme de ses actifs moins la somme de ses passifs.
Année | Actifs nets | Changement |
---|---|---|
2024-03-31 | $€0.87 Md | -20.71% |
2023-03-31 | $€1.09 Md | -1.44% |
2022-03-31 | $€1.11 Md | 35.92% |
2021-03-31 | $€0.82 Md | 12.41% |
2020-03-31 | $€0.72 Md | 1.56% |
2019-03-31 | $€0.71 Md | 3.24% |
2018-03-31 | $€0.69 Md | -2.42% |
2017-03-31 | $€0.71 Md | 25.67% |
2016-03-31 | $€0.56 Md | 28.08% |
2015-03-31 | $€0.44 Md | 21.7% |
2014-03-31 | $€0.36 Md | -9.07% |
2013-03-31 | $€0.40 Md | 11.93% |
2012-03-31 | $€0.35 Md | 9.19% |
2011-03-31 | $€0.32 Md | -16.28% |
2010-03-31 | $€0.39 Md | 64.41% |
2009-03-31 | $€0.23 Md | -1.52% |
2008-03-31 | $€0.24 Md | 102.82% |
2007-03-31 | $€0.11 Md | 63.55% |
2006-03-31 | $€72.87 M | 25.27% |
2005-03-31 | $€58.17 M | 32.19% |
2004-03-31 | $€44 M |